Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment

NCT05790213 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT05790213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05790213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 18, 2028
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer